9 Recruiting Ovarian Cancer Clinical Trials in Alabama
Explore active ovarian cancer research studies enrolling across Alabama. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Ovarian Cancer Studies in Alabama
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Trial of Vigil for Participants With Ovarian Cancer
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
📍 Usa Mitchell Cancer Institute /ID# 269661 — Mobile, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
📍 University of Alabama at Birmingham ( Site 0006) — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
📍 Usa Health Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
📍 O'Neal Comprehensive Cancer Center at UAB — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
📍 The University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
📍 The University of Alabama — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
📍 University of Alabama at Birmingham Womens & Infants Center — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
📍 004 — Birmingham, Alabama
View Study & Checklist ➔